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I~  Early referral to a specialised centre is associated with a better 
respiratory outcome 
P. Lebecque 1 , G. Casimir 2, E De Baets 3, K. De Boeck 4, K. Desager 5, V Godding 1, 
A. Malfroot s, G. Reychler l, T. Leal 1. 1UC Louvain; 2UL Bruxelles; 3UZ Ghent; 
4 KU Leuven; 5 UI Antwerpen; 6 VU Brussels, Belgium 
Background:  Specialised CF care is long recognised as a major prognosis factor. Yet, 
published evidence supporting it remains limited and is often hampered by comparisons 
with historical controls. 
Hypothes is :  Could there be differences in outcome variables between children referred 
to specialised centres less than 2 years after the diagnosis and those referred later? 
Methods :  In this retrospective multicentric study, data from all CF children fulfilling 
the following criteria were collected: (1) Age 6 <18 at the end of 2003; (2) diagnosis 
before By; (3) follow-up in one of the 6 main CF Belgian centres; (4) at least 1 
spirometry and respiratory culture available for 2003. Group A included children 
referred ~>2 years after the diagnosis. Each patient from group A was then matched 
with a single early referred patient on the basis of 3 criteria: same sex, same centre, 
as closest age as possible (Group B). 
Resu l ts :  Data from 218 children were collected (Group A: 61/218 28%, 29M/32F). 
Results are reported in the table. 
Group A Group B p 
Age (y), n~+SD 13.4±3 13±2.7 NS 
AF508/AF508 (%) 61 61 
Median age at diagnosis (y) 0.2 0.2 
Median delay diagnosis/referral (y) 6.9 0.2 
Weight (median Pc) 26 31 
Height (median Pc) 36 44 
FEV1 (% pr.), m±SD 76±21 86±19 
% Pseudomonas aeruginosa (end 2003) 43 28 
<0.0001 
NS 
NS 
<0.05 
<0.05 
Conc lus ion :  In Belgium, at age 13, children referred to a specialised CF centre less 
than 2 years after the diagnosis have a significantly better FEV1 and a lower prevalence 
of PA than those referred later. Important differences in mean FEV1 were observed 
between centres (range: 74 95% pred.). This study also provides indirect evidence 
supporting neonatal screening 
~kong term non-invasive positive pressure ventilation is 
associated with a stabilisation in the decline of lung function 
B. Fauroux 1, E. Le Roux 2'3, S. Ravilly 2, G. Bellis 3, A. Cldment 1. 1pediatric 
pulmonology and INSERM U 719, H@ital A Trousseau, 2Vaincre la Mucoviscidose, 
3 INED, Paris, France 
Aims:  Several short term studies have demonstrated that non invasive positive 
pressure ventilation (NPPV) is able to improve alveolar hypoventilation and gas 
exchange during wakefulness, sleep, physiotherapy and exercise in Cystic Fibrosis, 
but long term benefits have not been demonstrated. The aim of the study was to 
evaluate the benefit of  NPPV in patients with severe lung disease after one year of 
treatment. 
Methods:  Patients from the national CF registry who were started on NPPV (n 53) 
were compared to matched controls (n 53), one year before the initiation of NPPV, 
during the year of NPPV initiation, and after one year of NPPV treatment. Each 
patient of the NPPV group was matched with a control patient for gender, CFTR 
genotype, age ± 1 yr, weight ± 2 kg, FEV1 ± 10% predicted, and follow up in 
the same CF centre. For the 2 groups, the following parameters were compared one 
year before the start of  NPPV (year 1), the year of NPPV initiation (year 0), and 
one year after the start of  NPPV (year +1): weight, body mass index, vital capacity 
(VC), FEV1, arterial blood gases, number of intravenous (IV) antibiotic courses. 
Resu l ts :  At year 1, the 2 groups were comparable with regard to age, nutritional 
status, genotype, VC, FEV1, PaO 2, PaCO 2, the number of IV antibiotic courses 
and days with IV antibiotics. At year 0, the NPPV group had a significantly greater 
decline in VC and FEV1, more IV antibiotic courses. At year +1, the decline in 
VC and FEV1 was similar in the 2 groups, demonstrating a stabilisation of lung 
function decline in the NPPV group. 
Conc lus ion :  These data show for the first time that NPPV is associated with a 
stabilisation of the decline in lung function in patients with severe lung disease. 
$51 
~ Pulmonary function and growth in children with CF in relation to 
Pseudomonas aeruoginosa (PA) status and treatment regimen: 
an observational study 
S. Sanka, A. Khan, N. Vuppali, C. Thornton, E. Lloyd, M. Dixon, J. Vyas, T.J. David, L. Patel. 
gaediatric Cystic Fibrosis Service, Central Manchester and Manchester Childrenk University 
Hospitals, Manchester, UK 
Aim: To compare pubnonary fimction mid growth in relation to PA antibiotic susceptibility status 
and treatment regimen. 
Methods: Patients attending a single tertiary centre but managed by different antibiotic regimen 
(Group A, age 0.8 18.2 y: elective 3-montlfly IV antibiotics; Group B, age 0.4 17.3 y: rescue 
antibiotics) were studied retrospectively. They were subdivided by PA status: no PA, PA with no 
antibiotic resistance (s-PA) mid PA with resistance (r-PA) on in-vitro testing using Modified Stokes' 
method (to cefiazidime, meropenem, tobramycin, piperacillLn, colistin and/or ciprofloxacin) from Jan- 
Mar 2004. Outcome measures were: best FEV 1 (in those >7 y age) expressed as % predicted; height 
(Ht), weight (Wt) and BMI expressed as standard eviation scores (SDS) using UK 1990 standards. 
Results: The distribution of Gp A patients by PA status did not differ from gp B (P 0.4). Gp A 
patients with no PA had higher Ht mid Wt SDS than gp B but FEV 1 mid BMI did not differ (Table). 
Gp B patients with r-PA l/ad lower FEV 1 tl/an gp A (Table). 
No PA s-PA r-PA 
Gtp A Gtp B Gila A Gtp B Gtp A Gtp B 
n 48 n 42 n 22 n 12 n 26 n 16 
FEVI%* 97 (64 146) 90 (48 123) 87 (41 114) 79 (39 111) 801 (3~104) 601 (33 110) 
BMI SDSt 0.1 (1.3) 0.3 (1.0) 0.3 (1.1) 0.1 (1.0) 0.5 (1.1) 0.3 (1.1) 
Wt SDSt 0.1 (1.2) 2 1.0 (1.2) 2 0.4 (1.3) 0.6 (1.1) 1.1 (1.5) 1.1 (1.5) 
Ht SDS~ 0.3 (1.1) 3 1.1 (1.3) 3 0.4 (1.3) 1.0 (1.1) 1.1 (1.4) 1.2 (1.4) 
*lTledian (i~llge); ~l~all (SD); 1p 0.04; 2p<0.001; 3p 0.002. 
Conclusion: Compared to rescue treatment, an elective treatment regimen was associated with betier 
pulmonary fimction in patients with antibiotic resistant PA. However, the clinical benefits of an elective 
regimen did not include betier nutritional state and linear growth. 
• Non-invasive ventilation (NIV): experience of 
Cystic Fibrosis Center of Geneva 
R. Casciaro, A. Amisano, G. Ottonello, A. Giannattasio, A. DeAlessandri, 
L. Minicucci, R. Lorini. Cystic Fibrosis Cente~ G. Gaslini Institute, Genoa, Italy 
Non-invasive ventilation (NIV) includes all techniques that do not need a tracheal 
prothesis; N IV revolutioned the management of patients (pts) with respiratory 
insufficiency, reducing use of invasive mechanical ventilation and its related com- 
plications. In literature several articles deal about NIV in adults, but not in pediatric 
pts. N IV has been used in Cystic Fibrosis (CF) pts awaiting for lung transplantation 
(LT). 
We describe our experience in 2 CF pts: 
R.C., age 17, was awaiting for LT since Oct 2004. In Nov 2004, after a worsening 
of the clinical conditions with acute hypoxic hypercapnic respiratory failure, was 
started to Biphasic Positive Airway Pressure finalized to overcome acute event. NIV~ 
in association with conventional therapies, produced a progressive improvement of 
clinical conditions (reduction of cough and dyspnoea) and a decrease of venous 
hypercapnia (101.5 mmHg vs 71.2 mmHg). She continued NIV overnight reporting 
a remission of awaking symptomatology related to the nocturnal hypercapnia 
(headache and weakness). In Jan 2006, R. received LT. 
EE, age 15, is waiting for LT since Oct 2005. In Nov 2005, after the begininng of 
parenteral nutrition, E felt headache, dispnoea and severe hypercapnia; we decided 
to start N IV with low pressure (Ipap 14 cm H20, Epap 2 cm H20, Pressure Support 
mode) because of a pneumothorax (PNX) without clinical symptoms, occurred 
10 months before. An improvement of the clinical symptomatology was observed 
immediately. 20 days after discharge, E was admitted for dyspnoea and severe 
desaturation. X-ray showed left PNX. 
Conc lus ions :  NIV is an important reatment of CF pts awaiting for LT. Past PNX 
is not an absolute controindication to NIV, but it could be helpful for small time 
during acute events. 
